Probiotic Supplement as Treatment for Students With ADHD
NCT02908802 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2018-09-12
Summary
Subjects will answer the following questionnaire and tests:
* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
* Demographic Questionnaire - composed by the researchers
* Family Eating Habits Questionnaire (FEAHQ-33)
* Food Frequency Questionnaire (FFQ)
* Test MOXO
The subjects will take the study product for six months.
After six months the subject will fill once again all the questionnaires.
Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
- DIETARY_SUPPLEMENT
-
Probiotic
Probiotic
- DIETARY_SUPPLEMENT
-
Placebo
Probiotics capsules without the active ingredient
Sponsors & Collaborators
-
Tel Hai College
lead OTHER
Principal Investigators
-
Snait Tamir, Professor · [email protected]
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2019-09-30
- Completion
- 2019-10-31
More Related Trials
-
PDC-1421 Treatment in Adult Patients With ADHD
NCT05202327 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder
NCT02315651 ·Status: UNKNOWN ·Phase: NA
-
PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
NCT03172481 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
NCT01685281 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
NCT03325881 ·Status: COMPLETED ·Phase: PHASE3
-
A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )
NCT02059642 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT03618030 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622 ·Status: COMPLETED ·Phase: NA
-
Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00704990 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
NCT04569357 ·Status: COMPLETED ·Phase: PHASE3
-
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02083783 ·Status: COMPLETED ·Phase: PHASE3
-
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
NCT02623114 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
NCT02163915 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial of Two-Week Brain Stimulation for Teenagers With ADHD
NCT05102864 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication
NCT00561340 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects
NCT02189772 ·Status: COMPLETED ·Phase: PHASE2
-
Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective
NCT03563573 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
NCT00483106 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
NCT06359899 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
NCT00610441 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate in KBG Syndrome: N-of-1 Series
NCT06465641 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
NCT02737033 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega-3 Supplementation to ADHD Medication in Children
NCT02204410 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
NCT00531752 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
NCT00179894 ·Status: COMPLETED ·Phase: NA